Next health emergency to reveal impact of patient visitor law … $11M NIH grant to support evaluation of Alzheimer’s screening tool in primary care … COVID rebound uncommon among patients treated...
ProMedica tackles ‘false’ portrayal of incoming operating partner for 147 sites
By
Joe Bush
Dec 09, 2022
Criticism of a new Welltower skilled nursing operating partnership drove down the real estate investment trust’s stock price Wednesday, but current operator ProMedica said Thursday that a damning report...
Lawmakers seek to bolster Medicare, Medicaid mental health coverage
By
Alicia Lasek
Dec 07, 2022
Senators cited constituent concerns about so-called ghost networks — listings of physicians who are unavailable to provide care.
New wave of flu cases, COVID-19 hospitalizations hits U.S., impacting seniors
By
Alicia Lasek
Dec 06, 2022
Flu activity was the highest in a decade last week and hospitalizations for three respiratory viruses are straining healthcare systems, CDC Director Rochelle Walensky said on Monday.
Providers have big shoes to fill with infection preventionists
By
John Hall
Dec 05, 2022
Infection preventionists should expect their responsibilities to grow as the industry continues grappling with
workforce issues.
Clinical briefs for Thursday, Dec. 1
By
Alicia Lasek
Dec 01, 2022
Drug overdoses in seniors climb between 2000 and 2020 … Predictive clinical tool determines 5, 9 and 13-year risk of dementia … Remdesivir and corticosteroids tied to better COVID acute-care outcomes...
Amid ProMedica ouster, advocates question new operator’s qualifications
By
Kimberly Marselas
Nov 30, 2022
Weeks after Welltower announced it plans to transition its ProMedica portfolio to a new operator, consumer advocates and mainstream media are questioning the track record of the selected firm.
Stanford to test antiviral pills as long COVID treatment
By
Alicia Lasek
Nov 28, 2022
Investigators plan to test whether the antiviral drug Paxlovid will relieve symptoms of the syndrome known as long COVID, also called post-acute sequelae of COVID-19.
NIH: ‘Good’ cholesterol may not universally predict heart disease risk
By
Alicia Lasek
Nov 28, 2022
In a study of 23,000 people, high HDL cholesterol levels were not associated with reduced cardiovascular disease risk, and low levels predicted increased heart disease in white but not Black adults.
Clinical briefs for Tuesday, Nov. 22
By
Alicia Lasek
Nov 22, 2022
FDA: Philips recalls some previously replaced Trilogy ventilators … Anti-hyperglycemic drugs raise risk of MS in patients with diabetes … NIH awards $12M for developing antivirals against viruses...